Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
Insulin 2 endocrinologydiseasesdrugs
diabetes mellitus 1 endocrinologydiseases
metformin 1 endocrinologydiseasesdrugs
obesity 1 endocrinologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Insulin 19722 for further therapeutic actions in order to decrease TB-DM prevalence in developing Asian countries. Insulin resistanceA very high prevalence of insulin resistance in Asian populations may contribute to susceptibility
Insulin 21246 capacity in macrophages, that act as the first line of defence against M. tuberculosis invasion [[75]]. Insulin resistance is reported even in children and adolescents of Asian Indian origin [[76]]. Normally, insulin
metformin 30813 Diabetes Association (CDA) also applies WHO recommendations on TB management, advising the use of insulin, metformin , sulphonylurea derivatives, and thiazolidinediones in patients with dual disease [[96]].There are not
Select Disease Character Offset Disease Term Instance
diabetes mellitus 327 /2017Publication date (epub): 1/2017AbstractABSTRACTBackground: The double burden of tuberculosis (TB) and diabetes mellitus (DM) is hitting certain Asian countries harder than other areas. In a global estimate, 15% of all TB
obesity 26586 of anti-TB and DM drugs, and comorbidities that affect the clinical course, such as hypertension and obesity [[71],[84],[85]]. Treatment failure occurs in 4.8% of TB-DM patients compared with a failure rate of

You must be authorized to submit a review.